690 studies found for:    Alexander Disease
Show Display Options
Rank Status Study
21 Withdrawn Study of the Safety and Effectiveness of Rilonacept (IL-1 Trap) Administered Subcutaneously in Subjects With Non Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) and Anemia
Conditions: Chronic Kidney Disease;   Anemia
Intervention: Drug: Rilonacept
22 Recruiting A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors
Conditions: Cardiovascular Disease;   High Cardiovascular Risk;   Obesity;   Overweight;   Type 2 Diabetes
Interventions: Drug: APD356-Lorcaserin hydrochloride;   Drug: Placebo
23 Recruiting Executive Functioning in TBI From Rehabilitation to Social Reintegration: COMPASS
Conditions: Traumatic Brain Injury;   Post-Traumatic Stress Disorder
Interventions: Behavioral: Experimental - COMPASS;   Behavioral: Control - COMPASS
24 Recruiting Kappa Opioid Receptor Imaging in Depression (KOR Depression)
Conditions: Major Depressive Disorder;   Anhedonia
Intervention: Other: Positron Emission Tomography (PET) imaging
25 Recruiting Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: PF-02545920;   Other: Placebo
26 Recruiting Levetiracetam for Alzheimer's Disease-Associated Epileptiform Activity
Condition: Early-onset Alzheimer's Disease
Intervention: Drug: levetiracetam
27 Not yet recruiting Group Versus Internet-based Cognitive Behavior Therapy for Procrastination
Condition: Procrastination
Interventions: Behavioral: Cognitive behavior group therapy;   Behavioral: Internet-based cognitive behavior therapy
28 Terminated Safety and Efficacy Study of PB127 Ultrasound Contrast Agent for Diagnosis of Coronary Artery Disease
Condition: Coronary Artery Disease
Intervention: Drug: PB127 for Injectable Suspension
29 Completed Behavioral Activation for Posttraumatic Stress Disorder (PTSD)/ Depression Treatment in Operations Iraqi Freedom and Enduring Freedom (OIF/OEF) Veterans
Conditions: Posttraumatic Stress Disorder;   Depression
Interventions: Behavioral: Behavioral Activation treatment;   Other: Usual VA Treatment for PTSD
30 Terminated
Has Results
SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study
Condition: Major Depressive Disorder
Intervention: Drug: SPD489 (Lisdexamfetamine dimesylate) + Antidepressant
31 Completed
Has Results
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Antidepressant + SPD489 (Lisdexamfetamine dimesylate );   Drug: Antidepressant + Placebo
32 Completed
Has Results
Randomized Study Comparing Genz-644470, Placebo, and Sevelamer Carbonate in Chronic Kidney Disease Patients on Hemodialysis
Condition: Kidney Failure, Chronic
Interventions: Drug: Placebo;   Drug: Genz-644470;   Drug: Sevelamer carbonate
33 Active, not recruiting Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Donepezil
Condition: Alzheimer's Disease
Interventions: Drug: PF-05212377 (SAM-760);   Other: Placebo
34 Unknown  A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage
Condition: Small Cell Lung Cancer
Intervention: Drug: Carboplatin plus Irinotecan vs Carboplatin plus Etoposide
35 Unknown  Psychological Effects of Tai Chi Training
Condition: Attention Deficit Disorder With Hyperactivity
Intervention: Behavioral: Tai Chi training
36 Completed Safety and Effectiveness Study of BCI-540 Versus Placebo in the Treatment of Major Depressive Disorder With Concomitant Anxiety
Conditions: Major Depressive Disorder;   Anxiety
Intervention: Drug: BCI-540
37 Recruiting A Pilot Treatment Study of Insulin-Like Growth Factor-1 (IGF-1) in Autism Spectrum Disorder
Condition: Autism Spectrum Disorder
Interventions: Drug: IGF-1;   Drug: Placebo/saline
38 Completed Dose Finding Study of PB127 Ultrasound Contrast Agent in Healthy Volunteers and Patients With Coronary Artery Disease
Conditions: Healthy;   Coronary Artery Disease
Intervention: Drug: PB127 for Injectable Suspension
39 Recruiting Fevarin® Effectiveness in Treatment of Depression in Patients With Neurological Disorder
Condition: Depression
Intervention:
40 Terminated
Has Results
One-Year Trial of Oral Ziprasidone in Bipolar Patients With Metabolic Syndrome
Condition: Bipolar Disorder
Intervention: Drug: Ziprasidone HCL (oral)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years